liver tumors

MINNEAPOLIS, Minn., July 13, 2026 HistoSonics has achieved a major international regulatory milestone after receiving CE Mark approval for...

WESTMINSTER, Colo. – May 4, 2026 TriSalus Life Sciences has announced the initiation of patient enrollment for its PREDICTT...

DENVER, USA – March 18, 2026 TriSalus Life Sciences has announced new preclinical findings demonstrating that its Pressure-Enabled Drug...